We treated two AML cell lines (OCI-AML3 and MV4-11) and primary AML apheresis samples with IFNβ (500 U/mL) for 24 hours and tested their ability to phagocytose antibody-opsonized target cells, here opsonized sheep red blood cells. The gene discussed is IFNB1; the disease is acute myeloid leukemia.